Apotheca Biosciences, Inc.
CIK 0001632053
Revenue (TTM)
$0
Q1 Jun 2019
Net Income (TTM)
−$2.35M
−1,183.3% YoY
Q1 Jun 2019
EPS Diluted (TTM)
—
Q1 Jun 2019
Gross Margin
—
Q1 Jun 2019
Operating Margin
—
Q1 Jun 2019
Net Margin
—
Q1 Jun 2019
Free Cash Flow (TTM)
−$129.19K
Q1 Jun 2019
Cash
$250.48K
Q1 Jun 2019
Total Debt
—
Q1 Jun 2019
Shares Outstanding
118.66M sh
Q1 Jun 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.